Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma

Chinese Journal of Oncology

Volumn 33, Issue 1, 2011, Pages 28-31

  Guo, Yong Shun ^a   Dai, Yu Ping ^b   Li, Wen ^b   Liu, Lu Dong ^b  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

^b NONE

Author keywords

Gene expression; Macrophage migration inhibitory factor; Prognosis; Urinary bladder neoplasm

Indexed keywords

BIOLOGICAL MARKER; MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KAPLAN-MEIER ESTIMATE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 80053405139     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.01.006     Document Type: Article

References (11)

1. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med, 2002, 30(1 Supp):S27-S35.
2. Shun CT, Lin JT, Huang SP, et al. Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol, 2005, 11:3767-3771.
3. Ren Y, Law S, Huang X, et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg, 2005, 242:55-63.
4. Meyer-Siegler KL, Leifheit EC, Vera PL. Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer, 2004, 4:34.
5. Taylor JA 3rd, Kuchel GA, Hegde P, et al. Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC Cancer, 2007, 7: 135.
6. Verjans E, Noetzel E, Bektas N, et al. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer, 2009, 9:230.
7. Kamimura A, Kamachi M, Nishihira J, et al. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer, 2000, 89:334-341.
8. Liao H, Bucala R, Mitchell RA. Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF). J Biol Chem, 2003, 278:76-81.
9. Hudson JD, Shoaibi MA, Maestro R, et al. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med, 1999, 190:1375-1382.
10. Kip1 is instigated by Jab1. Nature, 1999, 398: 160-165.
11. Kleemann R, Hausser A, Geiger G, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jabl. Nature, 2000, 408:211-216.